Should we apply for listing gain
Krsnaa Diagnostics Limited IPO
(i) It is a large and differentiated diagnostic service provider. It provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and teleradiology services to public and private hospitals, medical colleges and community health centres pan-India.
(ii) It also operates one of India’s largest teleradiology reporting hubs in Pune that is able to process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year. It mainly focus on the public-private partnership (“PPP”) diagnostics segment and has the largest presence in the diagnostic PPP segment. It has deployed 1,781 diagnostic centres pursuant to PPP agreements with public health agencies. It operates 1,801 diagnostic centres offering radiology and pathology services in 13 states across India
(iii) It offers a range of diagnostics imaging services and clinical laboratory tests that include both routine and specialized tests/studies and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
In 2020 it had a team of 121 radiologists, 33 pathologists, 7 microbiologists and more than 2,300 qualified professionals including clinicians, technicians and operators.
(iv) It continues to make investments in equipment and in our technology platform, to ensure they meet requisite industry standards and accreditations like NABL and NABH. Its diagnostic equipment is procured from leading OEMs including Wipro GE Healthcare Private Limited, Siemens Healthcare Private Limited, Fujifilm India Private Limited, HORIBA India Private Limited and Agappe Diagnostics Limited.
(i) Unique and scaled diagnostics company
(ii) Strong brand equity
(iii) Extensive footprint across India
Objects of the Krsnaa Diagnostics Limited IPO:
Krsnaa Diagnostics Limited IPO Details:
|Open Date:||Aug 04 2021|
|Close Date:||Aug 06 2021|
|Face Value:||₹ 5 Per Equity Share|
|Issue Type:||Book Building|
|Issue Size:||1211 Cr.|
|Lot Size:||15 Shares|
|Issue Price:||₹ 933 - 954 Per Equity Share|
|Listing Date:||Aug 16 2021|
Promoters And Management:
Financials of Krsnaa Diagnostics Limited IPO:
|Particulars (in Cr.)||Mar-21||Mar-20||Mar-19||Mar-18|
|Gain on fair value movement||252|
|Cost of Material Consumed||83||27||17||10|
|Fees to hospitals and others||108||75||62||17|
|Loss on fair value movement of CCPS||0||177||95||89|
|Employee Benefits Expense||29||23||18||16|
|Profit before tax||295||-158||-77||-84|
|Total Tax Exps.||110||-46||-19||-24|
|No. of shares||3.1||3.1||3.1||3.1|
|EPS in Rs||15||-35||-18||-19|
Comparison With Peers:
|Name of the company||3-year Revenue Growth||3-year PAT Growth||EBITDA Margin (FY21)||ROE (FY21)||Debt to Equity||P/E||3 Years Return|
|Krsnaa Diagnostics Ltd||24%||NA||91%||79.76%||0.87||NA||NA|
|Metropolis Healthcare Ltd||9%||15%||29%||29.70%||0.16||79.70||NA|
|Dr. Lal PathLabs Ltd||10%||14%||30%||25.13%||0.00||75.15||56.12%|
Recommendation on Krsnaa Diagnostics Limited IPO:
Lead Manager of Krsnaa Diagnostics Limited IPO:
Registrar of Krsnaa Diagnostics Limited IPO:
Discussion on Krsnaa Diagnostics Limited IPO:
What is the meaning of “Loss on fair value movement of CCPS” and why it is zero in year 2020.
is it accounting trick to show profitability?
Leave a Reply
You must be logged in to post a comment.